Molecular Allergy Diagnostics Innovation For A Better Patient Management at Meripustak

Molecular Allergy Diagnostics Innovation For A Better Patient Management

Books from same Author: KLEINE-TEBBE J

Books from same Publisher: SPRINGER

Related Category: Author List / Publisher List


  • Retail Price: ₹ 18053/- [ 11.00% off ]

    Seller Price: ₹ 16067

Sold By: MeriPustak      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 11.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 11.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)KLEINE-TEBBE J
    PublisherSPRINGER
    ISBN9783319424989
    Pages531
    BindingHardbound
    LanguageEnglish
    Publish YearMay 2017

    Description

    SPRINGER Molecular Allergy Diagnostics Innovation For A Better Patient Management by KLEINE-TEBBE J

    This book, based on a recent German publication, offers an overview of basic data and recent developments in the groundbreaking field of molecular allergology. It comprehensively explores the origin and structure of single allergen molecules ("components") and their utility in improving the management of type I, IgE-mediated allergic reactions and disorders like allergic respiratory diseases, food allergies, and anaphylaxis. Highly specific testing, called component-resolved diagnostics, aims to identify and utilize single molecules. Over 200 single allergens from plant or animal sources have been applied to single or multiplex laboratory testing for the presence of allergen-specific IgE. This leap in assay sensitivity and specificity has led to three major advances in patient management: discrimination between primary allergic sensitization and complex cross-reactivity, recognition of IgE profiles for certain allergens and identification of patients most likely to benefit from allergen-specific immunotherapy.